menu
    • menu

    Company profile for Cornerstone Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cornerstone Pharmaceuticals is committed to the development of therapies for rare cancers that have few to no treatment options available. Cornerstone’s lead compound, CPI-613® (devimistat), is designed to target the mitochondria of cancer cells in order to disrupt their energy production, cutting off the fuel for disease growth. Devimistat is undergoing multiple clinical trials and has been granted orphan drug designati...
    Cornerstone Pharmaceuticals is committed to the development of therapies for rare cancers that have few to no treatment options available. Cornerstone’s lead compound, CPI-613® (devimistat), is designed to target the mitochondria of cancer cells in order to disrupt their energy production, cutting off the fuel for disease growth. Devimistat is undergoing multiple clinical trials and has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the following indications: Burkitt’s lymphoma, biliary tract cancer, soft tissue sarcoma, myelodysplastic syndrome (MDS) and peripheral T-cell lymphoma.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cornerstone PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    520 Broad Street, Cranbury, NJ 07102
    Telephone
    Telephone
    (609) 409-7050
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cornerstonepharma.com/about-us
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cornerstonepharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rafael Pharma Announces Name Change to Cornerstone Pharmaceuticals, Inc.
    Rafael Pharma Announces Name Change to Cornerstone Pharmaceuticals, Inc.

    19 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/19/2447011/28235/en/Rafael-Pharmaceuticals-Inc-Announces-Corporate-Name-Change-to-Cornerstone-Pharmaceuticals-Inc.html

    GLOBENEWSWIRE
    19 May 2022
    Share Share
    Rafael Completes Enrollment in Phase 2 Trial of CPI-613 in biliary tract cancer
    Rafael Completes Enrollment in Phase 2 Trial of CPI-613 in biliary tract cancer

    18 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/18/2368484/28235/en/Rafael-Pharmaceuticals-Announces-Ongoing-Successful-Enrollment-and-Opening-of-Additional-Sites-for-Phase-2-Clinical-Trial-of-CPI-613-Devimistat-in-Combination-with-Gemcitabine-and-.html

    GLOBENEWSWIRE
    18 Jan 2022
    Share Share
    Rafael Pharma Completes Dose Escalation in APOLLO 613 Phase 1/2 Trial of CPI-613
    Rafael Pharma Completes Dose Escalation in APOLLO 613 Phase 1/2 Trial of CPI-613

    06 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/06/2362450/28235/en/Rafael-Pharmaceuticals-Announces-Successful-Completion-of-Dose-Escalation-with-No-Dose-Limiting-Toxicity-DLT-in-First-Cohort-of-APOLLO-613-Phase-1-2-Clinical-Trial-of-CPI-613-Devim.html

    GLOBENEWSWIRE
    06 Jan 2022
    Share Share
    Rafael resets after phase 3 flop, parting ways with 5 execs
    Rafael resets after phase 3 flop, parting ways with 5 execs

    24 Nov 2021

    // L. Lindner ROI-NJ

    https://www.roi-nj.com/2021/11/23/healthcare/rafael-holdings-realigns-leadership-team-to-support-earlier-stage-pipeline-focus/

    L. Lindner ROI-NJ
    24 Nov 2021
    Share Share
    Rafael Begins Enrollment in Phase 1/2 Trial of CPI-613 in Clear Cell Sarcoma
    Rafael Begins Enrollment in Phase 1/2 Trial of CPI-613 in Clear Cell Sarcoma

    11 Nov 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/11/11/2332725/28235/en/Rafael-Pharmaceuticals-Announces-First-Patient-Enrolled-in-APOLLO-613-Phase-1-2-Clinical-Trial-of-CPI-613-Devimistat-in-Patients-with-Relapsed-Clear-Cell-Sarcoma.html

    GLOBENEWSWIRE
    11 Nov 2021
    Share Share
    Telecom tycoon's phase 3 pancreatic cancer bet flames out
    Telecom tycoon's phase 3 pancreatic cancer bet flames out

    29 Oct 2021

    // Michael Dabaie MARKETWATCH

    https://www.marketwatch.com/story/rafael-pharma-shares-down-75-after-pancreatic-cancer-trial-didn-t-meet-primary-endpoint-271635424625

    Michael Dabaie MARKETWATCH
    29 Oct 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search